Author:
Newman Erika A.,Chukkapalli Sahiti,Bashllari Daniela,Thomas Tina T.,Van Noord Raelene A.,Lawlor Elizabeth R.,Hoenerhoff Mark J.,Opipari Anthony W.,Opipari Valerie P.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology
Reference43 articles.
1. Wilzén, A. et al. The Phox2 pathway is differentially expressed in neuroblastoma tumors, but no mutations were found in the candidate tumor suppressor gene PHOX2A. Int. J. Oncol. 34, 697–705 (2009).
2. Cheung, N.-K. V. & Dyer, M. A. Neuroblastoma: developmental biology, cancer genomics and immunotherapy. Nat. Rev. Cancer. 13, 397–411 (2013).
3. Weiss, W. A. Targeted expression of MYCN causes neuroblastoma in transgenic mice. EMBO. J. 16, 2985–2995 (1997).
4. Zhu, S. et al. Activated ALK collaborates with MYCN in neuroblastoma pathogenesis. Cancer. Cell. 21, 362–373 (2012).
5. Zimmerman, K. A. et al. Differential expression of myc family genes during murine development. Nature. 319, 780–783 (1986).
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献